IP Library › Assignment 029454/0515
Patent Assignment
Reel/Frame 029454/0515

Change of Name

Recorded: 2012-12-12 Pages: 7
Assignor
TALIGEN THERAPEUTICS, INC.
Executed: 2011-01-28
Assignee
ALEXION CAMBRIDGE CORPORATION
245 FIRST STREET, SUITE 1100, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (2)
Humaneered Anti-Factor B Antibody
Patent: 7,964,705 →
Application: 12/049,233 →
Publication: US 2008/0299114
Humaneered Anti-Factor B Antibody
Application: 13/115,810 →
Publication: US 2011/0318337
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 9, 2008
From: EMLEN, WOODRUFF; HOLERS, V. MICHAEL; FLYNN, PETER
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 021215/0595 →
Assignment of Assignor's Interest Dec 12, 2012
From: EMLEN, WOODRUFF; HOLERS, V. MICHAEL; FLYNN, PETER
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 029454/0711 →
Change of Address Feb 12, 2013
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029801/0586 →
Merger Jun 19, 2015
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 035866/0477 →
Confirmatory License Jan 26, 2018
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045169/0549 →